Funktionsmenü_neu

Hauptnavigation

Sub-Navigation
Klickpfad

Investor Conference Call
Update on Nexavar Melanoma Program

Monday, December 4, 2006

at: 2.00 p.m. CET (1:00 p.m. GMT)

Back to overview

Investor News Monday December 04, 2006

Phase III Trial of Nexavar in Patients with Advanced Melanoma Does Not Meet Primary Endpoint


Here you find full details of the investor conference call on the Nexavar melanoma program:

MP3 audio recording of the presentation and discussion
to top

You are leaving the Bayer AG website.

Bayer AG is not responsible for the information on the website to which you are linking.

Latest Reports and Handout